Alzheimer’s Drug Aduhelm Faces Crucial Medicare Decision

Medicare officials are trying to determine whether to cover Aduhelm, which the F.D.A. approved despite unclear evidence that it helps patients.

F.D.A. Plans to Allow 12- to 15-Year-Olds to Receive Pfizer Boosters

Regulators will also allow even younger children with immune deficiencies to get an extra shot.

Teva Pharmaceuticals Found Liable in Landmark Opioid Trial

The case was the first of its kind, targeting every point of the prescription opioid supply chain, from manufacturers to pharmacy chains that filled prescriptions.

J. & J. Booster Protects Against Severe Omicron, Study Says

Two shots of the vaccine reduced the risk of hospitalization from the fast-spreading variant by 85 percent, a clinical trial found.

Una alternativa a las gafas: gotas para los ojos

Un tratamiento que puede ayudar a la gente que necesita anteojos para ver de cerca, sin afectar su visión de largo alcance, salió al mercado en diciembre tras ser aprobado por la FDA en octubre.

South Korea approves Pfizer’s coronavirus pill for emergency use.

It is the first pill approved in the nation to treat symptoms of the coronavirus.

Merck’s Covid Pill Is Authorized by F.D.A. for High-Risk Adults

The F.D.A. said the drug should be prescribed mainly when other treatments were “not accessible or clinically appropriate.”

Beneath a Covid Vaccine Debacle, 30 Years of Government Culpability

Washington has rejected plans to revamp vaccine preparedness for decades and repeatedly paid a price. The Biden administration is at a similar crossroads.

Beneath a Covid Vaccine Debacle, 30 Years of Government Culpability

Washington has rejected plans to revamp vaccine preparedness for decades and repeatedly paid a price. The Biden administration is at a similar crossroads.